fda curbs weight‑loss drugs

fda curbs weight‑loss drugs

Prescription Weight Loss: FDA Cost Busters?

The FDA’s tighter rules on GLP-1 compounding are set to raise the price of prescription weight-loss drugs and shrink the number of pharmacies that can supply them. In practice, patients may see higher copays while insurers face new reimbursement challenges. According to a recent report, Americans could spend more